Tracet is used to help manage the overall symptom burden associated with moderate to severe acute pain, which is discomfort that interferes significantly with routine activities. It is applied in clinical settings that involve acute or unstable symptom patterns, as commonly used across conditions presenting with acute episodes. The medication is appropriate for addressing symptoms related to physical discomfort, which may include painful episodes associated with sprains, strains, certain injuries, or discomfort arising from the muscles and joints, such as that linked to moderate osteoarthritis. The combination is indicated for these clinical applications.

---

“It is relevant when supportive symptom management is appropriate for episodes where discomfort becomes temporarily overwhelming.”

---

Quick Fact: Support for Symptomatic Episodes

Tracet offers symptomatic relief that helps patients cope more steadily with difficult episodes. It is applied when symptoms create noticeable physiological strain, and is considered relevant for managing episodes where symptoms may intensify temporarily. The use of this medicine supports general well-being during symptomatic phases and is applied when groups of symptoms appear suddenly or fluctuate.

Tracet (Tramadol/Acetaminophen) eligibility is strictly defined by regulatory documents, confining its use to adults 18 years and older who do not have documented contraindications. Use is generally restricted to patients whose pain requires this specific combination.

Contraindications (Must Not Use)

• Pediatric Patients: Contraindicated in all children younger than 12 years. It is also prohibited for post-operative pain management in adolescents under 18 following tonsillectomy or adenoidectomy.
• Organ Impairment: Patients with severe hepatic impairment or severe renal impairment (creatinine clearance <10 ml/min) must not use this medicine.
• Concomitant Drugs: Prohibited if taking Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping MAOI therapy.
• Acute States: Contraindicated in cases of acute intoxication by alcohol, hypnotics, opioids, or psychotropic drugs, or in patients with uncontrolled epilepsy.

Restricted and Non-Recommended Use

• Moderate Impairment: Patients with moderate renal or hepatic impairment require careful dose adjustments or prolonged dosing intervals.
• Reproductive Status: The medicine is not recommended during pregnancy (especially the first and third trimesters) or for breastfeeding mothers.

Interactions with other medicines and products

Official regulatory documentation identifies several categories of substances and medicines that interact with Tracet (Acetaminophen and Tramadol Hydrochloride), primarily through pharmacokinetic and pharmacodynamic mechanisms.

Contraindicated Combinations and Mandatory Restrictions

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly prohibited due to the risk of Serotonin Syndrome and opioid crisis. A mandatory 14-day washout period is required after discontinuing an MAOI before Tracet can be administered. Co-administration with Alcohol is also strictly prohibited due to the risk of additive Central Nervous System (CNS) depression, potentially leading to profound sedation and respiratory depression.

Documented Pharmacokinetic Interactions

Substances affecting the cytochrome P450 (CYP) enzymes can alter drug exposure. CYP2D6 inhibitors (e.g., fluoxetine, quinidine) may reduce the formation of the active tramadol metabolite, resulting in reduced analgesic effect. CYP3A4 inhibitors (e.g., ketoconazole) may increase tramadol plasma concentrations, while CYP3A4 inducers (e.g., carbamazepine) may reduce them. The exposure to acetaminophen is also restricted; the co-use of other acetaminophen-containing products is constrained to prevent exceeding the regulatory limit.

Pharmacodynamic and Other Interactions

Co-administration with other CNS Depressants (e.g., benzodiazepines) or Serotonergic Drugs (e.g., SSRIs) can result in dangerous additive effects. The tramadol component may also interact with warfarin, potentially causing an increase in International Normalized Ratio (INR).

Tracet, a fixed-dose combination, exerts its effect through the synergistic actions of its two components, paracetamol and tramadol. The paracetamol component acts centrally, likely by inhibiting the enzyme cyclooxygenase (COX), preferentially the COX-2 isoform in the central nervous system (CNS). This inhibition blocks the synthesis of prostaglandins, which are key mediators of cellular signaling cascades in the spinal cord and perivascular spaces. Downstream, this action modulates the neurochemical environment, altering ascending pain signals.

The tramadol component functions as a centrally acting opioid agonist and a monoamine reuptake inhibitor. Tramadol and its active metabolite, O-desmethyl-tramadol (M1), interact with and act as agonists at the mu-opioid receptors in the CNS. This mu-opioid receptor activation modulates calcium and potassium conductance, leading to hyperpolarization and reduced neuronal excitability in afferent pathways. Concurrently, tramadol weakly inhibits the neuronal reuptake of norepinephrine and serotonin in the synaptic cleft. This increases the concentration of these neurotransmitters, enhancing the descending inhibitory pathways originating from the brainstem. The net systemic physiological consequence is the altered perception of and response to nociceptive input.

How to Use Tracet

The administration of the Tracet fixed-dose combination product is characterized by specific parameters concerning its route, dosing schedule, and duration of use. The medicine is supplied as an oral tablet and is to be taken with or without food. The tablet is swallowed whole with liquid.

---

Dosage and Frequency Guidelines

The standard starting dose for adults is typically two tablets, which corresponds to 75 mg of Tramadol and 650 mg of Acetaminophen. Subsequent doses are typically one or two tablets taken every 4 to 6 hours as required. The time interval between any two doses is not less than six hours to manage the plasma concentration of its components.

The maximum intake does not exceed eight tablets (300 mg Tramadol / 2600 mg Acetaminophen) over a 24-hour period. The therapeutic application is generally limited to a maximum duration of five days.

---

Population-Specific Use and Restrictions

Adjustments are utilized for specific patient populations. For individuals with moderate renal impairment (creatinine clearance < 30 mL/min), the dosing interval is extended to 12 hours. For older adults (over 75 years of age), a minimum 6-hour dosing interval is recommended. A key restriction is the constraint against concurrent use with any other medicine containing either tramadol or acetaminophen.

Research Evidence / Overview of Studies for Tracet

The following summary describes the types of clinical research that have been conducted to evaluate the Tracet combination, outlining the study designs, the outcomes that were measured, and where evidence remains incomplete or uncertain, based on official regulatory and scientific reviews.

---

Evidence for Use in Acute Pain

Research for acute pain primarily involves short-term, highly controlled studies. These randomized controlled trials (RCTs) compare the combination against a placebo or its individual components to understand symptom patterns. Studies were mainly conducted during periods of increased symptom activity in otherwise healthy adults and adolescents (aged 12 years and older).

Research explored patterns related to the time reported until initial relief for the combination versus tramadol alone in specific acute models. Evidence currently provides limited insight regarding the combination's evaluation outside of these standardized, short-duration acute pain models. Longer-term outcomes beyond the immediate acute phase remain insufficiently characterized by this body of research.

---

Evidence for Use in Chronic Pain Conditions

Research exploring the combination in persistent conditions involved intermediate-term RCTs. These studies monitored adults with Chronic Low Back Pain (CLBP) or conditions characterized by functional limitations, like symptomatic Osteoarthritis (OA). The trials typically lasted intermediate durations and were used in observational settings evaluating daily-life functioning.

Studies monitored measurements related to systemic or functional imbalance. Data show patterns related to changes in pain scores measured during the study period; however, findings for functional change and quality of life were observed in some studies but often showed more variability.

---

Research Gaps and Uncertainties

A key research gap relates to long-term evaluation. The follow-up durations for the key clinical trials are limited, meaning that long-term effects are not fully established. For specific patient populations, such as frail older adults or those with complex comorbidities, data remain insufficient. The results apply only to the populations studied, and the evidence quality varies across studies when examining sustained changes in functional limitations.

Key Studies & References

1. Tramadol and Acetaminophen Combination for Chronic non-Cancer Pain - WorkSafeBC (Includes reference to Cochrane reviews on OA and CLBP)
2. Tramadol hydrochloride/acetaminophen combination for the relief of acute pain

Common questions about Tracet (FAQ)

---

Q: How quickly does Tracet start working after you take it?

Regulatory documents indicate that the tramadol component of the combination product generally begins to exert its pain-relieving effect within an hour of administration. The highest concentrations of the medicine in the body are typically reached in approximately two to three hours.

---

Q: How long does the effect of one dose of Tracet last?

The official dosing schedule defines the required interval between doses. According to official product information, the pain-relieving effects of the tramadol component are generally described as lasting for approximately six hours.

---

Q: What are the most commonly reported side effects of Tracet?

Official regulatory documents categorize the most frequent effects. The very common side effects reported are nausea, dizziness, and somnolence (drowsiness). Common effects also include vomiting, constipation, dry mouth, and headache.

---

Q: Is it normal to feel a little dizzy after starting Tracet?

Dizziness is officially listed as a very common side effect of the medication. Official information also notes that the most common effects are often reported to occur more frequently during the initial period when treatment is first started.

---

Q: Does the time of day matter when taking Tracet?

The medicine is prescribed to be taken as needed for pain relief, with a mandatory interval of not less than six hours between doses. Official instructions state that it may be taken with or without food, providing for its administration based on pain relief needs and the required interval.

---

Q: Are there specific storage requirements for Tracet?

Official product information mandates that the medicine must be stored at a controlled room temperature, protected from moisture and excessive heat. Due to the presence of an opioid component, it must be kept securely out of the sight and reach of children to prevent accidental overdose.

---

Q: Is Tracet the same kind of medicine as [similar drug name]?

Tracet is a fixed-dose combination product containing two active ingredients: the opioid agent tramadol and the non-opioid agent acetaminophen, making it a centrally acting analgesic. This dual nature distinguishes it from single-ingredient pain relievers.

---

Q: Can Tracet be taken at the same time as cold medicine?

Official warnings advise caution when taking Tracet alongside any medication that may cause drowsiness, known as a central nervous system (CNS) depressant. This is because combining these types of medicines may increase the risk of serious effects, such as profound sedation.

---

Q: Are there any foods or drinks that should be avoided when using Tracet?

Official regulatory documents strictly prohibit combining the medication with alcohol due to the increased risk of additive CNS depression, which may lead to profound sedation and respiratory problems. There are no other specific food restrictions mentioned.

---

Q: Does Tracet cause weight changes?

Official adverse event reports occasionally include side effects related to appetite, such as a loss of appetite. However, weight change itself is not listed among the most commonly reported side effects (Very Common or Common categories).

---

Q: What happens if I forget to take my Tracet dose?

Official patient information outlines a procedure for a missed dose, which includes taking it as soon as it is remembered unless it is almost time for the next dose. The guidance also states that double or extra doses are not to be taken.

---

Q: Can I take Tracet if I have kidney issues?

Official regulatory guidelines state that the medicine is strictly prohibited (contraindicated) in cases of severe renal impairment. For patients with moderate renal impairment, specific guidelines mandate that the time interval between doses must be extended.

---

Q: Why do some people say Tracet didn't work for them?

The pain-relieving action of the tramadol component relies on being converted into an active form by the CYP2D6 enzyme in the body. Regulatory warnings note that reduced effectiveness can occur in individuals who are considered poor metabolizers of the tramadol component.

---

Q: Does Tracet show up on drug tests?

The tramadol component of the medicine is classified as an opioid agent and is a scheduled controlled substance. Because of this classification, it may be detected in drug screenings that are specifically designed to identify this class of substance.

---

Q: How long does Tracet stay in your system?

According to official pharmacokinetics data, the elimination half-life of the tramadol component is reported as approximately 6.3 hours. The active ingredients are generally eliminated from the system within roughly two days after the last dose.

---

Q: Is Tracet a narcotic or controlled substance?

The tramadol component of Tracet is a prescription medicine classified as an opioid analgesic and is regulated by the U.S. federal government as a Schedule IV controlled substance.

---

Q: Can Tracet cause problems with sleep?

Official adverse reaction reports include both somnolence (drowsiness) and insomnia (trouble sleeping) as reported side effects of the medication.

---

Q: Are there warnings about driving while taking Tracet?

Official warnings state that the medicine may cause drowsiness or dizziness. The patient information indicates that driving or operating machinery should be avoided while these effects are present.

---

Q: Does Tracet interact with herbal supplements like St. John's Wort?

Official warnings advise caution when using Tracet with other serotonergic drugs because of the risk of Serotonin Syndrome. St. John's Wort is recognized as having effects that influence serotonin levels.

---

Q: Is it possible for Tracet to stop working after a while?

Official patient information notes that physical tolerance to the medication may develop. This means that, over time, a person might require a higher dose to achieve the same level of pain relief.

---

Q: If Tracet works for me, how long can I expect to use it?

The medication is indicated for short-term use only. Official regulatory guidelines restrict its usage to a maximum duration of five days or less.

---

Q: Is there a generic version of Tracet available?

Multiple manufacturers market generic versions of the tablet, which contain the same active ingredients (tramadol/acetaminophen combination).

---

Q: Can taking Tracet affect fertility?

Official documents state that the chronic use of opioids may cause reduced fertility. However, it is unknown whether these specific effects are reversible.

---

Q: Is it possible to have an overdose on Tracet?

Official boxed warnings indicate that accidental ingestion or exceeding the maximum recommended dose can result in a fatal overdose due to the tramadol component. Signs of overdose may include slow breathing, severe drowsiness, and seizures.

---

Q: Does Tracet interact with alcohol?

Co-administration with alcohol is strictly prohibited due to the risk of additive central nervous system depression. This interaction can lead to profound sedation, coma, and death.

---

Q: Can taking Tracet affect my mood?

The medicine's mechanism involves inhibiting the reuptake of neurotransmitters like serotonin. Official adverse events reported in regulatory documents include mood changes, nervousness, and anxiety.

---

Q: Is Tracet a maintenance or an as-needed medication?

The medication is indicated for short-term use of five days or less. Official instructions state that it is to be taken 'as needed' for pain relief.

---

Storage and Disposal Requirements

Official regulatory documents define strict rules for the storage and disposal of Tracet (Acetaminophen and Tramadol HCl) tablets.

Item	Official Regulatory Requirement
Storage Temperature	Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C (86 F) [Source 1.3].
Protection	The product must be protected from moisture, excessive heat, and freezing, and should be stored in the original, tightly closed, light-resistant container [Source 1.3].
Child-Safety Storage	The medicine must be kept out of the sight and reach of children and stored securely due to the risk of accidental fatal overdose from the opioid component [Source 1.3, 2.3].
Disposal Instructions	Unused or expired medication should be disposed of by following a drug take-back program or, if unavailable, by flushing the tablets down the toilet immediately, as specified by U.S. FDA guidance for high-risk controlled substances [Source 1.4, 1.9].

These requirements, documented in the FDA Prescribing Information and European SmPC, ensure the medication's stability and mandate a secure and specialized disposal procedure.